Hood River Capital Management LLC Sage Therapeutics, Inc. Transaction History

Hood River Capital Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 13, 2020	SELL	$60.18 - $154.77 $22 Million - $56.7 Million	-366,068 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$140.29 - $189.96 $369,804 - $500,734	2,636 Added 0.73%	366,068 $51.4 Million
Q2 2019 Aug 13, 2019	BUY	$157.85 - $183.09 $2.06 Million - $2.39 Million	13,064 Added 3.73%	363,432 $66.5 Million
Q1 2019 May 14, 2019	BUY	$89.33 - $163.65 $18.7 Million - $34.2 Million	208,942 Added 147.74%	350,368 $55.7 Million
Q4 2018 Feb 13, 2019	BUY	$81.94 - $139.71 $145,853 - $248,683	1,780 Added 1.27%	141,426 $13.5 Million
Q3 2018 Nov 14, 2018	BUY	$138.11 - $169.04 $2.66 Million - $3.25 Million	19,238 Added 15.98%	139,646 $19.7 Million
Q2 2018 Jul 30, 2018	BUY	$140.36 - $175.76 $3.91 Million - $4.89 Million	27,825 Added 30.05%	120,408 $18.8 Million
Q1 2018 May 07, 2018	BUY	$152.15 - $192.33 $14.1 Million - $17.8 Million	92,583 New	92,583 $14.9 Million

198

46.5M

402K

209K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $417M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Hood River Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Hood River Capital Management LLC with notifications on news.